Status:
UNKNOWN
The Pathogenesis of Superior Limbic Keratoconjunctivitis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Superior Limbic Keratoconjunctivitis
Eligibility:
All Genders
20-80 years
Brief Summary
Superior limbic keratoconjunctivitis (SLK) was first described in detail as a clinical entity by Frederick Theodore in 1963. The clinical picture of SLK is well documented, but the etiology is still u...
Detailed Description
1. Specimens collection: We will collect the specimens in two different parts. One part is to collect all the paraffinized block of the SLK patients to get fifteen copies of 5-μm section of each p...
Eligibility Criteria
Inclusion
- Superior limbic keratoconjunctivitis patients who receive conjunctiva resection
Exclusion
- \-
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
End Date :
June 1 2006
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00167050
Start Date
July 1 2005
End Date
June 1 2006
Last Update
November 28 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan